ClinicalTrials.gg
Enrolling by invitationNCT06482424hypertensionUpdated Jul 1, 2024

The Effect of Aromatherapy on Sleep, Anxiety and Vital Signs in Those With Essential Hypertension (Hypertension)

An interventional study of intervention group in Hypertension and Aromatherapy, sponsored by TC Erciyes University. Enrolling by invitation at 1 site in Turkey. Open to participants aged 18 Months to 65 Months. Per ClinicalTrials.gov, last updated 2024-07-01.

Primary conditionEssential HypertensionRegistry: HypertensionReclassifiedWhy we changed it
Registry
Hypertension — the first condition term the registry derived for this study.
ClinicalTrials.gg
Essential Hypertension
Why
  1. The study's title name Essential Hypertension, a narrower term within Hypertension.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by TC Erciyes University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Months to 65 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Essential Hypertension with a site in Turkey — 6 open to participants now, 6 under way, none of them phase 3. Essential Hypertension · Turkey.

Planned enrollment
18th of 19
40 · median 130
Started
2024
with 3 others
No phase
11 of 21
5 open now
Registered
15th of 21
by date
Lead sponsor
2 of 21
TC Erciyes University

Among the 21 studies in Essential Hypertension with a site in Turkey, this one is the 18th largest by planned enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2024, is one of 11 with no phase, and was the 15th registered.

Essential Hypertension

481 studies on the registry are indexed under Essential Hypertension; 75 are open to participants now.

Browse Essential Hypertension studies →

Open to participants now

6 of the 21 studies in Essential Hypertension with a site in Turkey are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 43 Essential Hypertension studies recruiting now, 15 (35%) set no upper age limit and 20 (47%) stop at 75 or younger; 4 take children under 18; 11 take healthy volunteers.

This study: 18 Months to 65 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Essential Hypertension with a site in Turkey, or all of them as a file.
02

Study summary

In addition to pharmacological agents in the treatment of hypertension, it has been reported in studies that aromatherapy applications, one of the traditional and complementary alternative treatments that are easy to apply nursing interventions with minimal side effects, have an effect on high blood pressure control. Studies have shown that aromatherapy has positive effects on stress management and anxiety control. Lavender oil, one of the frequently used aromatic oils, has antiseptic, anti-inflammatory, analgesic, muscle relaxant effects, regulates sleep with its relaxing and sedative effects, reduces the severity of itching, increases attention and facilitates learning, and reduces physical indicators of the autonomic nervous system such as pulse, respiratory rate and blood pressure. It has been shown in studies that it lowers In this study, the effect of lavender aromatic oil on sleep, anxiety and vital signs in individuals with essential hypertension will be evaluated. In the study, lavender oil will be administered to patients by inhalation for 5 minutes twice a day for 4 weeks. Medicinal lavender oil will be applied to the intervention group, and sesame oil will be applied to the placebo group. During the follow-up of the patients, the patient follow-up chart-researcher form will be evaluated at the beginning of the first week and at the end of the fourth week for each group. Vital signs, blood pressure and pulse rate, half an hour before and after aromatherapy in the morning and evening, 5 days a week for four weeks, will be evaluated with the Pittsburgh Sleep Quality Index and State-Trait Anxiety Scale at the beginning of the first week and at the end of the fourth week. The unique value of this study is that, unlike other studies, the applications will be applied in the morning and evening for 4 weeks, and sesame oil, which does not have an aromatic effect, will be used in the placebo group. As an expected patient outcome, we foresee improving the quality of life of patients by improving their sleep quality, reducing their anxiety level, and lowering their blood pressure by taking advantage of the healing effect of lavender aromatic oil in nursing practices.

Read the detailed description

METHOD OF THE THESIS:

PURPOSE AND TYPE OF RESEARCH This study will be conducted as a randomized controlled experimental study to determine the effect of aromatherapy on sleep, anxiety and vital signs in individuals with essential hypertension.

HYPOTHESES H01: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on systolic blood pressure in patients with Essential Hypertension.

H11: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on systolic blood pressure in patients with Essential Hypertension.

H02: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on diastolic blood pressure in patients with Essential Hypertension.

H12: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on diastolic blood pressure in patients with Essential Hypertension.

H03: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on pulse rate in patients with Essential Hypertension.

H13: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on pulse rate in patients with Essential Hypertension.

H04: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on anxiety level in patients with Essential Hypertension.

H14: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on the anxiety level in patients with Essential Hypertension.

H05: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on sleep level in patients with Essential Hypertension.

H15: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on sleep level in patients with Essential Hypertension.

ETHICAL ASPECTS OF RESEARCH In order to conduct the research, Erciyes University Faculty of Health Sciences Department of Nursing Academic Board Decision, Niğde Bor State Hospital Institutional Permission and TR Ministry of Health Kayseri City Hospital GETAT Clinical Research Ethics Committee Approval will be obtained. The purpose of the research will be explained to the individuals participating in the research and written voluntary consent will be obtained.

PLACE AND TIME WHERE THE RESEARCH WILL BE CONDUCTED will be collected from patients treated at the internal medicine outpatient clinic of Niğde Bor State Hospital between 15.05-2024-31.12.2024 . Bor State Hospital has a capacity of 100 beds and employs 407 personnel. Bor State Hospital offers internal medicine, cardiology, gynecology, ophthalmology, orthopedics, general surgery, child health and diseases, skin and venereal diseases, anesthesiology and reanimation, psychiatry, infection , urology outpatient clinic service and general surgery, internal medicine, urology, orthopedics, women. Obstetrics, ophthalmology, internal medicine, infection, cardiology, child health and diseases, skin and venereal diseases, general intensive care, neonatal intensive care clinic services are provided. In the Bor State Hospital internal medicine outpatient clinic, patients who are not compliant with treatment and have a lack of knowledge are given training by a training nurse upon the request of a doctor. Drug treatment is administered to patients diagnosed with hypertension in the internal medicine outpatient clinic.

UNIVERSE AND SAMPLING OF THE RESEARCH consists of patients who were treated in the internal medicine outpatient clinic at Niğde Bor State Hospital between January 2022 and December 2022 . It was planned to include at least 20 people with essential hypertension in the intervention group and at least 20 people in the placebo group in the study sample. Groups will be selected according to similar characteristics in terms of variables such as gender, age the contact information of the patients who voluntarily participate in the study and meet the study conditions . After visiting the patients at home, the patient's allergy status will be observed by applying oil to the patient's wrist one day before starting aromatherapy . Patients without allergies will be evaluated in terms of the inclusion criteria and the study will be conducted with patients who meet the criteria.

COLLECTION OF DATA Actions to be taken to the Intervention Group Before the research, patients will be informed about the purpose and method of the study and then their approval will be obtained through an informed consent form. A personal information form will be filled out by the researcher for the patients in the intervention group, and an individual in-depth interview will be conducted with the questions in the oil application patient opinions form. The researcher will measure the temperature, respiratory rate, saturation level, blood pressure and pulse of the patients in the intervention group at their homes and will record them in the patient follow-up chart-researcher form. In the following days, patients will be called by phone and reminded to measure their blood pressure and pulse with a semi-automatic blood pressure monitor and record it on the patient follow-up chart-researcher form. In line with the lavender oil application protocol, patients in the intervention group will drop medical lavender oil on gauze and smell it for 5 minutes every morning and evening for 4 weeks. The patient will be instructed and reminded to record his/her blood pressure and pulse rate on the patient monitoring chart-researcher form five days a week, half an hour before and after aromatherapy in the morning and evening for 4 weeks.

The state-trait anxiety scale and Pittsburg Sleep Quality Index score will be recorded on the patient follow-up chart-researcher form by the researcher at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle.

03

Conditions studied

  • Hypertension
  • Aromatherapy

Browse trials for

Keywords

  • Aromatherapy
  • Essential Hypertension
  • Internal Medicine Nursing
04

In context

Essential Hypertension Reclassified

481 studies on the registry are indexed under Essential Hypertension; 75 are open to participants now.

This study's planned enrollment of 40 is below the median of 144 across 408 interventional studies indexed under Essential Hypertension.

Browse Essential Hypertension studies →

Lead sponsor

TC Erciyes University is the lead sponsor of 350 studies on the registry; 73 are open to participants now.

Compared within Essential Hypertension, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hypertension. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Months to 65 Months
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Research Inclusion Criteria

  • Those aged between 18-65,
  • Understands Turkish, has good cognitive functions and can communicate,
  • Followed with the diagnosis of essential hypertension for at least 1 year,
  • Those receiving antihypertensive medical drug treatment, - There has been no change in antihypertensive drug treatment for the last 1 month,
  • Do not have a chronic respiratory system disease (such as Asthma, ), which is important for the effectiveness of aromatherapy,
  • Non-pregnant,
  • Not receiving anxiolytic or hypnotic treatment for at least 6 months,
  • Regularly measures blood pressure at home with its own semi-automatic blood pressure monitor on the upper arm,
  • Not having any psychiatric diagnosis,
  • Patients who agree to participate in the study will be included in the study.

Criteria for Exclusion from the Study

  • Those under the age of 18 and over the age of 65,
  • Having difficulty in applying and understanding the treatment protocol,
  • Having a psychiatric disease that impairs cognitive functions, such as bipolar disorder or schizophrenia,
  • Having any respiratory system disease,
  • Those who are allergic to or sensitive to the scent of lavender oil,
  • Those who are in the process of trying antihypertensive treatment,
  • Cancer patients and those under follow-up,
  • Those who have a condition that prevents them from smelling,
  • Uses other integrative health practices in the treatment process,
  • Patients who do not agree to participate in the study will not be included
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    intervention group

    Actions to be taken to the Intervention Group The state-trait anxiety scale and Pittsburg Sleep Quality Index score will be recorded on the patient follow-up chart-researcher form by the researcher at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle.

    Other: intervention group

  • Experimental
    placebo group

    Procedures to be Performed on the Placebo Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. Sesame oil given to patients in the placebo group will be placed in 10 ml dark glass bottles with droppers and a label with number two will be attached to the bottle.

    Other: intervention group

Interventions

  • Otherintervention group

    Actions to be taken to the Intervention Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle. Procedures to be Performed on the Placebo Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. Sesame oil given to patients in the placebo group will be placed in 10 ml dark glass bottles with droppers and a number two label will be attached to the bottle.

    Also known as: placebo group

07

What researchers measure

Primary outcomes

  1. The Effect of Aromatherapy on Sleep, Anxiety and Vital Signs in Individuals with Essential Hypertension

    In this study, the effect of lavender aromatic oil on sleep, anxiety and vital signs in individuals with essential hypertension will be evaluated. In the study, patients will be administered lavender oil by inhalation for 5 minutes twice a day for 4 weeks. Medicinal lavender oil will be applied to the intervention group, and sesame oil will be applied to the placebo group.

    Time frame: 1 yıl

08

Study locations

1 site
  • Niğde Bor Devlet Hastanesi
    Merkez, Niğde 51200, Turkey
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2024; primary completion for Mar 2025, 6 months later.

Of 70 non-industry interventional studies with no phase under Essential Hypertension, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 47. This study's planned 6 months is below that.

Counting every sponsor, half of 80 studies reached it within 20 months; a quarter within 8 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2024
First posted
Jul 1, 2024
StartEst.
Sep 2024
Primary completionEst.
Mar 9, 2025
CompletionEst.
Sep 7, 2025
Last update
Jul 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06482424
Responsible party
esra doğan (Doktora Öğrencisi, TC Erciyes University) — Principal investigator
First posted
Jul 1, 2024
Start date
Sep 2024 (estimated)
Primary completion
Mar 9, 2025 (estimated)
Completion
Sep 7, 2025 (estimated)
Last update
Jul 1, 2024

Study contacts

esra doğan
principal investigator · esramercan11021985@gmail.com.tr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion